Overweightness
📧 Sign up to get email alerts when something new happens for Overweightness.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2022-10-28EMA confirms recommendation to withdraw marketing authorisations for amfepramone medicines
EMA confirms a recommendation to withdraw marketing authorisations for amfepramone medicines used for weight loss due to safety concerns.
-
CLINICAL_TRIALS trial_result · 2014-02-07Clinical Trial Update: Self-Weighing Instruction Feasibility Study [NA]
A completed feasibility study evaluating self-weighing instructions for weight loss interventions, with results posted in 2014.
-
EMA safety_alert · 2011-09-22European Medicines Agency starts review of orlistat-containing medicines
EMA has initiated a review of medicines containing orlistat to assess safety and quality concerns.